Our goal is to transform healthcare one investment at a time.
By supporting diverse entrepreneurs who create and build breakthrough companies and treatments.
Discover our Portfolio
We empower innovators to improve patients’ lives.
And we have the track record to prove it.
- $4.0Bin historical commitments
Global private equity and venture capital investment platform. Specialized and diversified healthcare funds spanning all sectors and stages. Three teams focused on biotechnology (inc dementia), healthcare growth equity and medtech.
View our Strategies
- 75IPOs/M&As
Backing inspiring and talented innovators with diverse experiences to create healthcare industry leaders that attract strategic acquirers and public investors. Our portfolio companies’ remarkable work benefits patients while growing shareholder value for investors.
View our Portfolio
- 30yrtrack record in US and UK
One of the longest-tenured healthcare investment managers in the world. Experienced team of >50 investment professionals and operating partners based in Boston and London, adding value and guiding strategic direction.
Meet our People
Our People
SV is driven by our talented team and network. We bring together our experienced investment professionals with healthcare industry veterans to build value in breakthrough life sciences companies.
Meet our People
The latest from SV
We're proud to share our achievements and those of our portfolio companies.
AdvanCell Closes US $315 Million Oversubscribed Series D Financing to Advance Targeted Alpha Therapies and Expand Clinical and Commercial Manufacturing Infrastructure
Draig Therapeutics Closes Oversubscribed $65 Million Series B to Accelerate Development of Highly Specific AMPA and GABAA Receptor Modulators in Neuropsychiatric Disorders
Alchemab Therapeutics announce biggest ever life sciences investment from British Business Bank to advance its AI-enabled clinical pipeline of next generation human-derived antibodies
